Stock listing
Sun Pharmaceutical Industries Limited
Selected listing: SUNPHARMA · NSE · INR · IN
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA), Health Technology. Latest release Oct 6, 2026: Sun Pharma Establishes Endowed Professorship at Mount…
- Ticker
- NSE:SUNPHARMA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NSE
- Currency
- INR
About Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited, trading under the ticker SUNPHARMA, is a leading pharmaceutical company based in India. Sun Pharma is recognized for its commitment to quality and innovation in the healthcare sector.
Latest news from Sun Pharmaceutical Industries Limited
Sun Pharma Establishes Endowed Professorship at Mount Sinai to Advance Dermatologic Care
October 6, 2026
New LEQSELVI® (deuruxolitinib) Two-Year Data in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026
October 1, 2026
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated October 01, 2026, titled "New LEQSELVI® (deuruxolitinib) Two-YearData in Severe Alopecia Areata Showed Sustained Efficacy and Safety at EADV Congress 2026".
October 1, 2026
LIB Therapeutics and Sun Pharma Announce Global Licensing, Commercialization and Manufacturing Agreement for Lerodalcibep, a Novel PCSK9 Inhibitor, Ex-US and China; Lerodalcibep (Lyrokaul®) Approved in the EU
September 28, 2026
Sun Pharmaceutical Industries Limited Press Release Sep 28 2026
September 27, 2026
Research Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited company profile
View the public company page for Sun Pharmaceutical Industries Limited on 6ix.
Sun Pharmaceutical Industries Limited news
Read company news and market updates connected to Sun Pharmaceutical Industries Limited.
Sun Pharmaceutical Industries Limited investor events
Find investor webinars, events, and replay context for Sun Pharmaceutical Industries Limited.